Effect of Coronary Thrombus Aspiration in Non ST Elevation Acute Coronary Syndrome Patients on Three-Year Survival- Does it add any Benefit?

dc.contributor.authorYildiz B.S.
dc.contributor.authorCetin N.
dc.contributor.authorGunduz R.
dc.contributor.authorBilge A.
dc.contributor.authorOzgur S.
dc.contributor.authorOrman M.N.
dc.date.accessioned2024-07-22T08:04:11Z
dc.date.available2024-07-22T08:04:11Z
dc.date.issued2022
dc.description.abstractWe assessed the effect of thrombus aspiration (TA) during percutaneous coronary intervention (PCI) on in-hospital and 3-year mortality in consecutive non-ST segment elevation myocardial infarction (n = 189) and unstable angina pectoris (n = 148) patients (n = 337) between 2011 and 2016. In total, 153 patients (45.4%) underwent TA. The number of patients with postoperative thrombolysis in terms of myocardial infarction grade 3 blood flow (P <.001) and myocardial blush grade 3 (P <.001) were significantly higher in all TA groups. At 6-, 12- and 24-month post-PCI, the mean left ventricular ejection fraction was significantly higher in the all TA groups versus the stand alone PCI group (P <.001). Thrombus aspiration was associated with a significant improvement both in epicardial flow, myocardial perfusion and left ventricular ejection fraction. Thrombus aspiration during PCI in all acute coronary syndrome (except ST segment elevation) patients was associated with better survival compared with stand alone PCI group at 3-year follow-up (P =.019). © The Author(s) 2022.
dc.identifier.DOI-ID10.1177/00033197211053404
dc.identifier.issn00033197
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/12573
dc.language.isoEnglish
dc.publisherSAGE Publications Inc.
dc.subjectAcute Coronary Syndrome
dc.subjectCoronary Angiography
dc.subjectCoronary Thrombosis
dc.subjectHumans
dc.subjectPercutaneous Coronary Intervention
dc.subjectStroke Volume
dc.subjectThrombectomy
dc.subjectTreatment Outcome
dc.subjectVentricular Function, Left
dc.subjectacetylsalicylic acid
dc.subjectangiotensin receptor antagonist
dc.subjectanticoagulant agent
dc.subjectantilipemic agent
dc.subjectantithrombocytic agent
dc.subjectbeta adrenergic receptor blocking agent
dc.subjectC reactive protein
dc.subjectcalcium channel blocking agent
dc.subjectclopidogrel
dc.subjectdipeptidyl carboxypeptidase inhibitor
dc.subjectfibrinogen receptor antagonist
dc.subjectglyceroltrinitrate
dc.subjecthemoglobin
dc.subjectheparin
dc.subjectnitrate
dc.subjectprasugrel
dc.subjecttroponin I
dc.subjectunclassified drug
dc.subjectacute kidney failure
dc.subjectadult
dc.subjectaged
dc.subjectalgorithm
dc.subjectangiography
dc.subjectarteriovenous fistula
dc.subjectartery catheterization
dc.subjectArticle
dc.subjectatrial fibrillation
dc.subjectballoon dilatation
dc.subjectbleeding
dc.subjectblood clot lysis
dc.subjectblood flow
dc.subjectbrain hemorrhage
dc.subjectcardiogenic shock
dc.subjectcardiovascular disease
dc.subjectcarotid arteriography
dc.subjectcerebrovascular accident
dc.subjectcohort analysis
dc.subjectcongestive heart failure
dc.subjectcontrolled study
dc.subjectcoronary angiography
dc.subjectcoronary artery blood flow
dc.subjectcoronary artery perforation
dc.subjectcoronary dissection
dc.subjectechocardiography
dc.subjectepicardial flow
dc.subjectestimated glomerular filtration rate
dc.subjectfeasibility study
dc.subjectfemale
dc.subjectfollow up
dc.subjectGRACE risk score
dc.subjectheart infarction
dc.subjectheart left bundle branch block
dc.subjectheart left ventricle ejection fraction
dc.subjectheart left ventricle volume
dc.subjectheart muscle perfusion
dc.subjectheart right bundle branch block
dc.subjectheart tamponade
dc.subjectheart ventricle fibrillation
dc.subjectheart ventricle tachycardia
dc.subjecthematoma
dc.subjecthuman
dc.subjectintraocular hemorrhage
dc.subjectlife expectancy
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmedical ethics
dc.subjectmiddle aged
dc.subjectnon st segment elevation acute coronary syndrome
dc.subjectnon ST segment elevation myocardial infarction
dc.subjectobservational study
dc.subjectpercutaneous coronary intervention
dc.subjectretrospective study
dc.subjectST segment elevation myocardial infarction
dc.subjectstent implantation
dc.subjectstent thrombosis
dc.subjectsurvival analysis
dc.subjectSYNTAX score
dc.subjecttarget lesion revascularization
dc.subjecttarget vessel revascularization
dc.subjectthrombectomy
dc.subjectthrombus aspiration
dc.subjectunstable angina pectoris
dc.subjectvery elderly
dc.subjectacute coronary syndrome
dc.subjectadverse event
dc.subjectcomplication
dc.subjectcoronary artery thrombosis
dc.subjectheart left ventricle function
dc.subjectheart stroke volume
dc.subjectpercutaneous coronary intervention
dc.subjecttreatment outcome
dc.titleEffect of Coronary Thrombus Aspiration in Non ST Elevation Acute Coronary Syndrome Patients on Three-Year Survival- Does it add any Benefit?
dc.typeArticle

Files